The US Centers for Disease Control and Prevention (CDC) reported a 50% increase in the prevalence of Diabetes Mellitus from 1997-2004, increasing by approximately 8% per annum. This corresponds with a 41% increase in the estimated number of diabetes related visits to physician’s offices and hospital outpatient departments.

Approximately 75 million Americans suffer from some type of endocrine disorder and/or related health issue, placing a substantial and rising burden on the US healthcare system. (Source: ADA) It has been estimated that diabetes and its complications alone utilize approximately 5% to 10% of the nation’s health budget. (Source: IDF) The World Health Organization (WHO) estimates that more than 1 billion people in the world are overweight and, if current trends continue, that number will reach 1.5 billion by 2015. In the USA alone, 59 million people are obese, and 40% of Americans will be obese in 5 years' time if nothing is done about this trend. Also, among people diagnosed with type 2 diabetes, 67 percent have a BMI greater than 27 (overweight) and 46 percent have a BMI greater than 30 (obese). 

As a result of the need for the most up to date information in this field, Sovereign Medical is producing US Endocrine Review to provide an in-depth analysis and overview of the endocrine market, focusing on the most relevant issues within diabetes, obesity and endocrine disorders, such as those of the pituitary, thyroid and adrenal glands as well as the range of sex-hormone-related issues.

The report will serve as a source of information for a targeted audience of medical doctors and professional caregivers involved in providing diagnosis, management and treatment regimens for a range of endocrine related disorders.

The publication contains specially commissioned clinical and scientific editorial from the principal thought leaders and key opinion leaders from within the US endocrinology sector, providing new clinical developments and therapies. Areas to be covered will include diabetes mellitus management, CVD and chronic kidney disease, hypertension and obesity.

US Endocrine Review draws on the expertise of key opinion leaders within the US Diabetes and Endocrine sector to ensure that it delivers world-class insights into the key developments and advancements within this vital clinical area.

Thought leaders and organisations that are being invited to contribute to the publication include:

• Richard M Bergenstal, MD Executive Director, International Diabetes Center
• Larry C. Deeb, MD, President, Medicine & Science, of The American Diabetes Association
• Gerard Doherty, MD Secretary, International Association of Endocrine Surgeons (IAES)
• Debbie Jones, Regional Chair, North America, International Diabetes Federation (IDF)
• Robert Knutzen, MBA Chairman of the Board and Chief Executive Officer, Pituitary Network Association (PNA)
• Jeffrey I Mechanick, MD Board of Directors, American Association of Clinical Endocrinologists (AACE)
• Malinda Peeples, immediate past president of the American Association of Diabetes Educators (AADE).

• International Diabetes Federation
• American Association of Clinical Endocrinologists
• National Kidney Foundation
• National Osteoporosis Foundation
• American Heart Association
• American Diabetes Association
• American Society of Bariatric Surgeons
• American Society of Bariatric Physicians
• American Society of Hypertension

The success of US Endocrine Review can be measured in the scope and depth of the publication's 15,000 readership, which spans medical doctors in primary and secondary care settings ranging from general practice to large general hospitals and centres of excellence across North America including:-

Endocrinologists Diabetologists Cardiologists Endocrine surgeons Nephrologists

Bariatricians including Surgeons Dietitians Selected high referring Primary care physicians Endocrinology nurses Diabetes nurses

Copies of the report will be distributed in both print and electronic format to selected members of the following professional associations in March 2009:-

American Association of Clinical Endocrinologists American Diabetes Association American Society of Bariatric Surgeons American Society of Bariatric Physicians American Society of Hypertension American Heart Association

International Diabetes Federation National Kidney Foundation National Osteoporosis Foundation Pituitary Network Association American Heart Association

We are able to provide you with

• The opportunity to nominate one author to write an independent unbiased white paper for the proposed feature running to approximately 2000 words
• A Search Engine Optimised Company Profile on the official US Endocrine Review website
• A fully guaranteed precisely targeted circulation
• The reader response service in operation for 12 months after publication
• A complimentary copy of US Endocrine Review upon publication
• A strategically placed advertisement in US Endocrine Review OR additional editorial if preferred

• Target senior level physicians and clinicians throughout the US Endocrinology market engaged in the diagnosis, treatment and management of endocrine related disorders.
• Reach Primary Care Physicians, Diabetologists and Endocrinologists.
• Demonstrate your commitment in this therapeutic area by sharing a platform with respected thought leaders and key opinion leaders.
• Increase your "share of voice" in the competitive market for diabetes and obesity products.